Laparoscopic splenectomy. The emerging standard.

The purpose of this study was to evaluate the outcome of patients undergoing laparoscopic splenectomy (LS) at the University of California, San Francisco.
The medical records of the initial 52 unselected patients undergoing LS were reviewed and compared to 28 concurrently treated open splenectomy patients (OS).
Patients did not differ with regard to age, gender, body, or splenic weights. The operative time was longer in the LS patients (mean 196 vs 156 min), but the length of stay and duration of ileus were shorter in the LS group. For adult patients admitted exclusively for splenectomy, operative times did not differ between LS and OS and total hospital cost was less in the LS group (mean $8, 939 vs $14,022). Six patients required conversion to OS, four occurring in the first 11 patients treated (overall conversion rate of 11%). Three patients died from complications related to their underlying disease. Two other major complications occurred. Complication rates and transfusion requirements did not differ between OS and LS patients.
Laparoscopic splenectomy is a safe and effective alternative to open splenectomy for treatment of hematologic diseases in patients of all ages.
AuthorsR E Glasgow, L F Yee, S J Mulvihill
JournalSurgical endoscopy (Surg Endosc) Vol. 11 Issue 2 Pg. 108-12 (Feb 1997) ISSN: 0930-2794 [Print] GERMANY
PMID9069137 (Publication Type: Comparative Study, Journal Article)
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Chi-Square Distribution
  • Child
  • Child, Preschool
  • Evaluation Studies as Topic
  • Female
  • Hematologic Diseases (physiopathology, surgery)
  • Humans
  • Laparoscopy (adverse effects, methods)
  • Length of Stay
  • Male
  • Middle Aged
  • Prognosis
  • Splenectomy (adverse effects, methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: